作者：
Jun,Itakura [1]
;
Masayuki,Kurosaki [2]
;
Satoru,Kakizaki [1]
;
Keisuke,Amano [2]
;
Nobuaki,Nakayama [3]
;
Jun,Inoue [4]
;
Tetsu,Endo [5]
;
Hiroyuki,Marusawa [6]
;
Chitomi,Hasebe [7]
;
Kouji,Joko [2]
;
Shuichi,Wada [8]
;
Takehiro,Akahane [2]
;
Youhei,Koushima [9]
;
Chikara,Ogawa [2]
;
Tatsuya,Kanto [10]
;
Masashi,Mizokami [2]
;
Namiki,Izumi [11]
作者单位：
Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Musashino, Tokyo, Japan.
[1]
Japanese Red Cross liver Study Group.
[2]
Department of Gastroenterology and Hepatology, Gunma University Graduate School of Medicine, Gunma, Japan.
[3]
Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Fukuoka, Japan.
[4]
Department of Gastroenterology & Hepatology, Faculty of Medicine, Saitama Medical University, Iruma-Gun, Saitama, Japan.
[5]
Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
[6]
Department of Gastroenterology and Hematology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
[7]
Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, Osaka, Japan.
[8]
Department of Gastroenterology, Japanese Red Cross Asahikawa Hospital, Asahikawa, Hokkaido, Japan.
[9]
Center for Liver-Biliary-Pancreatic Disease, Matsuyama Red Cross Hospital, Matsuyama, Ehime, Japan.
[10]
Department of Gastroenterology and Hepatology, Nagano Red Cross Hospital, Nagano, Japan.
[11]
Department of Gastroenterology and Hepatology, Ishinomaki Red Cross Hospital, Ishinomaki, Miyagi, Japan.
[12]
Department of Gastroenterology and Hepatology, Saitama Red Cross Hospital, Saitama, Japan.
[13]
Department of Gastroenterology and Hepatology, Takamatsu Red Cross Hospital, Takamatsu, Kagawa, Japan.
[14]
Department of Liver Disease, Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Ichikawa, Chiba, Japan.
[15]
Department of Genome Medical Sciences Project, Research Institute, National Center for Global Health and Medicine, Ichikawa, Chiba, Japan.
[16]
关键词
ALT, alanine aminotransferaseAST, aspartate transaminaseASV, asunaprevirBCV, beclabuvirCT, computed tomographyDAA, direct-acting antiviralDCV, daclatasvirDirect acting antiviralEBR, elbasvirFIB-4, Fibrosis-4GLE, glecaprevirGZR, grazoprevirHepatitis C virusIFN, interferonLDV, ledipasvirMRI, magnetic resonance imagingOBV, ombitasvirOR, odds ratioP32delPI, protease inhibitorPIB, pibrentasvirPTV/r, paritaprevir/ritonavirRAS, resistance-associated substitutionsRBV, ribavirinResistance-associated substitutionSOF, sofosbuvirSVR, sustained virological responseVEL, velpatasvir
DOI
10.1016/j.jhepr.2020.100138
PMID
32817930
发布时间
2022-04-16
换一批
换一批
